These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 19182897)
1. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. Griset AP; Walpole J; Liu R; Gaffey A; Colson YL; Grinstaff MW J Am Chem Soc; 2009 Feb; 131(7):2469-71. PubMed ID: 19182897 [TBL] [Abstract][Full Text] [Related]
2. Prevention of local tumor growth with paclitaxel-loaded microspheres. Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model. Liu R; Khullar OV; Griset AP; Wade JE; Zubris KA; Grinstaff MW; Colson YL Ann Thorac Surg; 2011 Apr; 91(4):1077-83; discussion 1083-4. PubMed ID: 21440127 [TBL] [Abstract][Full Text] [Related]
4. Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films. Liu R; Wolinsky JB; Walpole J; Southard E; Chirieac LR; Grinstaff MW; Colson YL Ann Surg Oncol; 2010 Apr; 17(4):1203-13. PubMed ID: 19957041 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded expansile nanoparticles in a multimodal treatment model of malignant mesothelioma. Schulz MD; Zubris KA; Wade JE; Padera RF; Xu X; Grinstaff MW; Colson YL Ann Thorac Surg; 2011 Dec; 92(6):2007-13; discussion 2013-4. PubMed ID: 21963198 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery. Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901 [TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Devalapally H; Shenoy D; Little S; Langer R; Amiji M Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429 [TBL] [Abstract][Full Text] [Related]
9. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model. Ma G; Yang J; Zhang L; Song C Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371 [TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization. Yu JM; Li YJ; Qiu LY; Jin Y J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
14. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery. Mandal BB; Kundu SC Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963 [TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of paclitaxel-loaded dual-responsive shell cross-linked polymer nanoparticles having orthogonally degradable disulfide cross-linked corona and polyester core domains. Samarajeewa S; Shrestha R; Elsabahy M; Karwa A; Li A; Zentay RP; Kostelc JG; Dorshow RB; Wooley KL Mol Pharm; 2013 Mar; 10(3):1092-9. PubMed ID: 23421959 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
17. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy. Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791 [TBL] [Abstract][Full Text] [Related]
18. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Wang XQ; Zhang Q Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. Patil Y; Sadhukha T; Ma L; Panyam J J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851 [TBL] [Abstract][Full Text] [Related]
20. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]